Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw.
Stockmann, Philipp
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. [electronic resource] - Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery Jan 2013 - 71-5 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1878-4119
10.1016/j.jcms.2012.10.018 doi
Adult
Age Factors
Aged
Aged, 80 and over
Alleles
Bisphosphonate-Associated Osteonecrosis of the Jaw--genetics
Bone Density Conservation Agents--administration & dosage
Case-Control Studies
Drug Combinations
Female
Gene Frequency--genetics
Genotype
HLA-DQ beta-Chains--genetics
HLA-DRB1 Chains--genetics
Haplotypes--genetics
Histocompatibility Antigens Class II--genetics
Humans
Injections, Intravenous
Linkage Disequilibrium--genetics
Male
Middle Aged
Multiple Myeloma--drug therapy
Polymorphism, Genetic--genetics
Risk Factors
Sex Factors
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. [electronic resource] - Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery Jan 2013 - 71-5 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1878-4119
10.1016/j.jcms.2012.10.018 doi
Adult
Age Factors
Aged
Aged, 80 and over
Alleles
Bisphosphonate-Associated Osteonecrosis of the Jaw--genetics
Bone Density Conservation Agents--administration & dosage
Case-Control Studies
Drug Combinations
Female
Gene Frequency--genetics
Genotype
HLA-DQ beta-Chains--genetics
HLA-DRB1 Chains--genetics
Haplotypes--genetics
Histocompatibility Antigens Class II--genetics
Humans
Injections, Intravenous
Linkage Disequilibrium--genetics
Male
Middle Aged
Multiple Myeloma--drug therapy
Polymorphism, Genetic--genetics
Risk Factors
Sex Factors